JAN SUNDE to Drug Administration Schedule
This is a "connection" page, showing publications JAN SUNDE has written about Drug Administration Schedule.
Connection Strength
0.014
-
A phase I trial of oxaliplatin and topotecan in recurrent ovarian carcinoma. Gynecol Oncol. 2007 Feb; 104(2):422-7.
Score: 0.014
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.